AtriCure, Inc.
ATRC
$32.44
-$0.27-0.83%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 123.62M | 124.28M | 115.91M | 116.27M | 108.85M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 123.62M | 124.28M | 115.91M | 116.27M | 108.85M |
| Cost of Revenue | 30.99M | 31.66M | 29.12M | 29.43M | 27.58M |
| Gross Profit | 92.63M | 92.62M | 86.79M | 86.84M | 81.27M |
| SG&A Expenses | 76.05M | 72.19M | 73.24M | 73.60M | 72.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 129.57M | 138.80M | 123.32M | 123.44M | 119.77M |
| Operating Income | -5.95M | -14.52M | -7.41M | -7.17M | -10.92M |
| Income Before Tax | -6.51M | -15.30M | -7.53M | -7.76M | -13.09M |
| Income Tax Expenses | 239.00K | 266.00K | 322.00K | 253.00K | 183.00K |
| Earnings from Continuing Operations | -6.75M | -15.57M | -7.85M | -8.01M | -13.27M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.75M | -15.57M | -7.85M | -8.01M | -13.27M |
| EBIT | -5.95M | -14.52M | -7.41M | -7.17M | -10.92M |
| EBITDA | -870.00K | -9.70M | -2.48M | -2.64M | -6.47M |
| EPS Basic | -0.14 | -0.33 | -0.17 | -0.17 | -0.28 |
| Normalized Basic EPS | -0.09 | -0.20 | -0.10 | -0.10 | -0.16 |
| EPS Diluted | -0.14 | -0.33 | -0.17 | -0.17 | -0.28 |
| Normalized Diluted EPS | -0.09 | -0.20 | -0.10 | -0.10 | -0.16 |
| Average Basic Shares Outstanding | 47.39M | 47.13M | 47.11M | 46.91M | 46.72M |
| Average Diluted Shares Outstanding | 47.39M | 47.13M | 47.11M | 46.91M | 46.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |